Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study

Authors :: Shaji K Kumar
Philippe Moreau
Nizar Jacques Bahlis
Thierry Facon
Torben Plesner
Robert Z. Orlowski
Supratik Basu
Hareth Nahi
Cyrille Hulin
Hang Quach
Hartmut Goldschmidt
Michael O'Dwyer
Aurore Perrot
Christopher P. Venner
Katja Weisel
Noopur Raje
Mourad Tiab
Margaret Macro
Laurent Frenzel
Xavier Leleu
Huiling Pei
Maria Krevvata
Robin Carson
Fredrik Borgsten
Saad Usmani
Source :: Blood. 140:10150-10153
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools